Obstetric anti-phospholipid syndrome: from pathogenesis to treatment
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by clinical manifestations such as thrombosis and obstetric complications with documented persistence of antiphospholipid antibodies (aPLs). Recent studies have revealed that the cause of aPL-related obstetric complications is dy...
Main Authors: | Kayoko Kaneko, Nobuaki Ozawa, Atsuko Murashima |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-08-01
|
Series: | Immunological Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/25785826.2021.1969116 |
Similar Items
-
Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS)
by: Khalid Abd Aziz Mohamed, et al.
Published: (2014-09-01) -
Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study
by: Víctor M. Martínez-Taboada, et al.
Published: (2022-11-01) -
Antiphospholipid Antibodies and Antiphospholipid Syndrome During Pregnancy: Diagnostic Concepts
by: Roger A Levy, et al.
Published: (2015-05-01) -
A Retrospective Study on the Association between Thyroid Autoantibodies with β2-glycoprotein and Cardiolipin Antibodies in Recurrent Miscarriage
by: Regina Promberger, et al.
Published: (2017-02-01) -
Anti-annexin as a marker in patients with recurrent miscarriages
by: Ahmed Rezk, et al.
Published: (2010-01-01)